Infermedica
Infermedica develops AI-powered clinical triage and patient navigation software certified as an EU MDR Class IIb medical device, serving health systems, insurers, telemedicine providers, and government health agencies across 30+ countries via its Neuro-Symbolic Medical Guidance Platform.
- Company typePrivate
- Founded2012
- HeadquartersWroclaw, Poland
- Headcount101–250
- GTM typeB2B
- OfferingSoftware
What Infermedica does
Infermedica is a digital health company that develops AI-powered clinical triage and patient navigation software for healthcare organizations. Founded in 2012 in Wroclaw, Poland, with a US operational headquarters in Denver, the company serves over 100 organizations across 30+ countries, targeting five primary verticals: public health systems and government agencies, health plans and insurers, healthcare providers, telemedicine companies, and pharmaceutical companies. Its flagship Medical Guidance Platform (MGP) is certified as a Class IIb medical device under EU MDR and combines Triage, Intake, and Follow-up modules delivered via iFrame embedding or API integration with 12-week enterprise implementation timelines.
The underlying technology is a Neuro-Symbolic AI architecture that pairs large language model interfaces with a probabilistic medical knowledge graph and explainable reasoning engine. The Medical Knowledge Base covers 900+ conditions, 1,800+ symptoms, and 340+ risk factors, developed through 155,000+ hours of physician validation, supporting 26 languages and achieving 96% condition accuracy in the Inference Engine. Recent product surface includes Conversational Triage (launched 2024-2025), a Voice Agent for call center pre-triage (launched July 2025), and forthcoming agentic AI capabilities for longitudinal patient management. The platform is supported by 20+ peer-reviewed clinical studies published in NEJM AI, Mayo Clinic Proceedings, JAMA, and NeurIPS.
Infermedica operates a multi-motion go-to-market combining direct enterprise sales, an API-first distribution model with a public developer portal, and a partner ecosystem that includes Microsoft Healthcare, AWS, Cisco/Outshift, and Healthdirect Australia. Revenue is generated through annual or multi-year subscriptions for the certified platform, usage-based API access to the Intelligent Core technologies, and professional services for enterprise integration. Named customers span Healthdirect Australia (national digital front door for 26 million citizens), Allianz Partners, Teladoc Health, Sana Kliniken AG, and major DACH insurers including Die Techniker, Barmenia Gothaer, and PZU Zdrowie. Total funding raised to date is $45 million, with a $30 million Series B closed in January 2022 led by One Peak.
Infermedica firmographics
Firmographics- Name
- Infermedica
- Legal name
- Infermedica
- Website
- https://infermedica.com
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Infermedica develops AI-powered clinical triage and patient navigation software certified as an EU MDR Class IIb medical device, serving health systems, insurers, telemedicine providers, and government health agencies across 30+ countries via its Neuro-Symbolic Medical Guidance Platform.
- Ownership category
- akta.pro rank
Infermedica industry classification
Industry- Product category
- Healthcare AI Clinical Decision Support
- NAICS
- Computer Systems Design and Related Services (54151)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs) (HLALAFAF)
- akta.pro secondary industry
- Medication Adherence & Therapy Management Platforms (refills, reminders, MTM) (HLALAIAG)
Keywords
Where Infermedica is headquartered
LocationHeadquarters
- HQ city
- Wroclaw
- HQ country
- Poland
- HQ region
- Europe
Offices2 records
Markets served
Infermedica business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- Medical Guidance Platform Subscription: Annual or multi-year subscription licensing of certified medical device software (Triage, Intake, Follow-up modules) deployed via iFrame or Platform API to healthcare organizations
- API Usage: API-based access to intelligent core technologies (Inference Engine, Knowledge Base, NLP) with usage-based integration into custom healthcare solutions
- Implementation Services: Professional services for enterprise integration and deployment, including technical support for strategic EHR systems
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise licensing with implementation |
| Usage-based | Pay-as-you-go | API access |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels9 records
Infermedica product offering
Product offeringCore offering
Infermedica develops and licenses a certified AI-powered Medical Guidance Platform (MGP) for symptom assessment, patient triage, pre-visit intake, and follow-up, deployed via iFrame or API to health systems, insurers, telemedicine providers, and government health agencies. The platform combines Neuro-Symbolic AI (LLMs with a probabilistic medical knowledge graph and reasoning engine) and is sold as a subscription-based medical device software covering 900+ conditions across 26 languages.
Differentiator
Problem solved
Functional benefit
Products and services
- Medical Guidance Platform (MGP) Unified certified medical device platform providing AI-powered patient triage and care navigation through chat, voice, or call center channels, with real-time symptom assessment and clinical decision support for healthcare organizations.
- Triage AI-powered virtual triage module for symptom assessment and medical guidance. Supports 5 triage levels (Self-care, Consultation, Consultation 24 hours, Emergency, Emergency ambulance) and covers 900+ conditions and 1,800+ symptoms across 26 languages.
- Intake AI-powered pre-visit patient intake module that automates collection and organization of essential health data before consultations. Collects symptoms, risk factors, chronic diseases, medications, hospitalizations, and allergies, and integrates with EHR systems.
- Follow-up AI-powered patient follow-up module for continuous symptom monitoring and care re-engagement, tracking symptom progression over time and connecting to prior assessments.
- Conversational Triage Agentic AI-powered conversational triage using a hybrid Neuro-Symbolic approach combining LLMs with a clinically validated medical reasoning engine to enable natural dialogue symptom assessment with transparent clinical reasoning and care navigation.
- Voice Agent Pre-triage voice agent for healthcare call centers using Neuro-Symbolic AI that combines Speech-to-Text, Text-to-Speech, and LLMs with a probabilistic knowledge graph to handle initial patient interactions, collect symptoms, and prepare structured handoffs to nurses.
- Infermedica API Public API providing access to Intelligent Core technologies including the Inference Engine (96% conditions accuracy), Medical Knowledge Base with 3,000+ medical concepts, and NLP for patient message analysis, enabling custom healthcare solution development with dynamic surveys and 5-level triage recommendations.
Quantifiable outcome
- 55% ED visits safely avoided through appropriate care routing
- +6 more outcomes
Companies that use Infermedica
Customer profileNamed customers12 records
Segments5 records
Ideal customer profiles5 records
Infermedica technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability9 records
Feature7 records
Infermedica partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core, flagship, strategic and supporting.
- Microsoft HealthcarecoreIntegration with Microsoft Healthcare Bot Service enabling customers to build intelligent virtual assistants. Infermedica's clinically validated health technology layered onto Microsoft's bot framework.
- Healthdirect AustraliaflagshipHealthdirect Australia testing integration with ChatGPT collaborating with Infermedica, Skin Analytics, AWS, and DEPT on AI health assistant project. Infermedica provides symptom triage technology for the national digital health service serving 26 million citizens.
- DocMorriscoreDocMorris integrated Infermedica's AI-powered symptom analysis to enhance telemedicine and pharmacy services. Beta rollout began October 2025 with AI-supported ecosystem for patient assessments.
- Outshift by CiscostrategicInfermedica collaborated with Outshift by Cisco, Webex, and AI vendors to develop healthcare automation prototype using multi-agent AI systems for patient interactions from symptom triage to appointment booking.
- AWS (Amazon Web Services)coreCloud infrastructure partner for Healthdirect Australia AI health assistant project, providing scalable cloud platform for the deployment.
- DEPT AgencysupportingDigital agency partner in Healthdirect Australia AI health assistant project, providing implementation and integration services.
- Skin AnalyticssupportingAI dermatology specialist collaborating on Healthdirect Australia project to provide comprehensive AI health assistant capabilities.
Scale indicators9 records
Recent moves6 records
Expansion highlights7 records
Infermedica competitors and assessment
Company assessmentDirect peers
- Ada Health: Berlin-based AI symptom assessment platform offering a consumer-facing app and enterprise API for payers and providers. Most direct peer to Infermedica — same AI-driven triage and care navigation offering, similar B2B go-to-market targeting health plans and providers.
- Hyro AI: Conversational AI platform for healthcare, offering virtual assistants for patient intake, triage, scheduling, and FAQ. Competes for similar conversational-AI-for-healthcare use cases (call center automation, digital front door) with health systems and payers.
- HealthTap: US virtual care platform combining AI symptom checking with telehealth consultations for health plans and consumers. Overlaps with Infermedica on the AI triage/pre-visit intake layer integrated into telemedicine workflows.
- Mediktor: Spanish AI symptom checker and pre-diagnosis platform targeting health systems, insurers, and telemedicine providers across Europe and Latin America. Closely comparable in product (symptom triage, multilingual support) and target buyer profile (insurers, hospitals, telemedicine).
- Buoy Health: US-based AI symptom checker and care navigation platform focused on health plans, employers, and providers. Comparable product offering (AI-guided triage, care routing) and similar enterprise sales motion targeting US payer and provider markets.
- Sensely: Virtual health assistant platform offering conversational AI avatars for symptom assessment, triage, and care navigation. Comparable in deploying AI-driven conversational interfaces into payer and provider workflows, with similar enterprise customer profile.
- K Health: US AI-driven primary care platform combining symptom assessment with virtual consultations. Overlaps with Infermedica on AI symptom intake and triage layer, though K Health also operates a clinical service alongside the technology.
- Babylon Health (now eMed): Originally a major AI triage and virtual care player serving national health services (NHS); restructured into eMed focused on GLP-1 telehealth. Previously the most direct global competitor to Infermedica in AI-powered symptom triage and digital front door deployments.
Broad incumbents
- Microsoft Healthcare Bot Service: Microsoft's broader healthcare conversational AI framework, with which Infermedica integrates as an intelligent clinical layer. Comparable as a healthcare conversational AI platform but operates as part of Microsoft's broader cloud and healthcare portfolio rather than specializing in clinically validated triage.
- WebMD (Internet Brands): Long-established consumer health information platform with a symptom checker tool used at massive consumer scale. Comparable on the consumer-facing symptom-check use case, but operates as a content/advertising business rather than a certified medical device sold to enterprise buyers.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks5 records
Key highlights7 records
Customer concentration
Infermedica social profiles
Digital presenceInfermedica compliance and trust
Trust signalCompliance11 records
Infermedica financial estimates
Financial estimateRevenue estimate
Valuation estimate
Infermedica leadership team
Management profileNumber of profiles
Profiles9 records
Infermedica funding detail
Funding detailFunding overview
Funding rounds11 records
Investors13 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Infermedica M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Infermedica
What does Infermedica do?
Infermedica develops and licenses a certified AI-powered Medical Guidance Platform (MGP) for symptom assessment, patient triage, pre-visit intake, and follow-up, deployed via iFrame or API to health systems, insurers, telemedicine providers, and government health agencies. The platform combines Neuro-Symbolic AI (LLMs with a probabilistic medical knowledge graph and reasoning engine) and is sold as a subscription-based medical device software covering 900+ conditions across 26 languages.
Is Infermedica a public or private company?
Infermedica is a private company. It is classified as venture growth investor backed and is currently operating.
When was Infermedica founded?
Infermedica was founded in 2012. It employs 101 to 250 people.
Where is Infermedica based?
Infermedica is headquartered in Wroclaw, Poland, in the Europe region.
How does Infermedica make money?
Three revenue lines are on record. Medical Guidance Platform Subscription is the primary driver. The others are API Usage and implementation Services.
Who are Infermedica's main competitors?
Direct peers on record are Ada Health, Hyro AI, HealthTap, Mediktor, Buoy Health, Sensely, K Health and Babylon Health (now eMed). Broad incumbents are Microsoft Healthcare Bot Service and WebMD (Internet Brands).
Does Infermedica have an API?
Yes. Infermedica offers a public API (API-first architecture) that provides access to the Intelligent Core technologies including the Inference Engine for real-time symptom assessment, the Medical Knowledge Base with 3000+ medical concepts, and Natural Language Processing capabilities. The API supports building custom healthcare solutions with dynamic patient surveys, 5-level triage recommendations, medical history collection, and educational content. Implementation typically takes 12 weeks. Supports ICD-10 and SNOMED mapping. Developer documentation is at developer.infermedica.com.
What industry is Infermedica in?
Infermedica's product category is Healthcare AI Clinical Decision Support. Its primary akta.pro industry code is HLALAFAF, Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs), with a secondary code of HLALAIAG, Medication Adherence & Therapy Management Platforms (refills, reminders, MTM). Its NAICS code is 54151 and its SIC code is 7372.